Strengthening Program for Pharmaceutical Startup Ecosystem
Funds Japanese pharmaceutical startups from preclinical to phase two growth with venture-collaborative backing.
The Strengthening Program for Pharmaceutical Startup Ecosystem is an AMED subsidy program that supports pharmaceutical startups carrying out practical drug development — covering non-clinical studies, Phase 1 trials, Phase 2 trials, and exploratory clinical trials — where a registered venture capital firm invests more than one-third of the total expenses covered by the subsidy. The program was est…
Vaccines, therapeutics, and drug discovery technologies across all disease areas (expanded from infectious disease only in October 2022).
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Sign up free to see where teams trip up